[ad_1] RT @ThomasCiullaMD: Pleased by the FDA’s acceptance of our IND for CLS-AX (axitinib injectable suspension), enabling initiation of a Phase… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Our #ARVO presentation was featured in @OphthTimes Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in #Macular Edema Due to #Retinal Vein Occlusion, #Diabetic Retinopathy and #Uveitis https://t.co/sQi7ts4dEF [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Interviewed for this recent piece on #Diabetic Macular Edema, a leading cause of #vision loss. More effective & longer acting #treatment is needed: Macular Edema Treatments Less Effective in the Real World https://t.co/dznSe1SpYI via @medscape
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Pleased by the FDA’s acceptance of our IND for CLS-AX (axitinib injectable suspension), enabling initiation of a Phase 1/2a clinical trial in neovascular AMD by the end of 2020! Our related recently-published ARVO abstract: https://t.co/tR0Wd8yueY #retina #biotech #medicine https://t.co/WiTT8ziDgs [ad_2] Source by Thomas Ciulla, …
[ad_1] RT @ThomasCiullaMD: Recently published…Diabetic macular edema, a leading cause of vision loss, is treated less intensely and shows worse… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
At the American Society of Retina Specialists meeting, our team & colleagues had numerous presentations on #retina clinical science as well as #suprachoroidal delivery of tyrosine kinase inhibitor, complement Inhibitor & corticosteroid.
#biotech #medicine #clinicalresearch
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @Ophthalmologymg: Update on gene therapy: Ocular gene therapy research has shown tremendous growth over recent years. This article discu… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Our study has generated much interest in #Luxturna #genetherapy #healtheconomics: Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Retinal Disease https://t.co/3DeMpzCgRq via @JAMAOphth part of @JAMANetwork [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @ThomasCiullaMD: Recently co-authored “Update on gene therapy: A discussion of strategies, optimization, alternatives and administration…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @VestrumHealth: https://t.co/On63W7xSpL [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.